Studio Investment Management LLC Accustem Sciences Inc. Transaction History
Studio Investment Management LLC
- $466 Million
- Q1 2025
About Accustem Sciences Inc.
- Ticker ACUT
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Description
- AccuStem Sciences, Inc. operates as a life sciences company focusing on improving outcomes for patients with cancer. It develops StemPrintER technology, a multi-gene prognostic assay to predict the risk of recurrence of Endocrine receptor-positive /HER2- breast cancer; and Spare, a derivative of StemPrintER that combines StemPrintER with two cli...